You are here:
dexamethasone (Ozurdex ®)
Advice
in the absence of a submission from the holder of the marketing authorisation
dexamethasone (Ozurdex ®) 0.7 mg intravitreal implant is not recommended for use within NHS Scotland.
Indication: Treatment of adult patients with inflammation of the posterior segment of the eye presenting as non-infectious uveitis.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Drug Details
| Drug Name: | dexamethasone (Ozurdex ®) |
|---|---|
| SMC Drug ID: | 751/11 |
| Manufacturer: | Allergan Ltd |
| Indication: | Treatment of adult patients with inflammation of the posterior segment of the eye presenting as non-infectious uveitis. |
| BNF Category: | |
| Sub Category: | 11.4 Corticosteroids and other anti-inflammatory preparations |
| Submission Type: | Non submission |
| Status: | Not Recommended |
| Date Advice Published: | 16 January 2012 |